PSIL Among Its Peers
End-of-day Nov 20, 2026 · 1 ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −4.6% | −13.3% | −20.3% | −35.6% | −2.9% | +3.4% | +40.5% | −78.5% | — | −80.6% |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$119 of every $1,000 in PSIL is Definium
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | DFTX | Definium Therapeutics | 11.88% |
| 2 | CMPS | Compass Pathways | 11.25% |
| 3 | HELP | Helus Pharma | 7.00% |
| 4 | LLY | ELI Lilly & | 6.61% |
| 5 | NBIX | Neurocrine Biosciences | 6.16% |
| 6 | ABBV | Abbvie | 6.02% |
| 7 | RLMD | Relmada Therapeutics | 5.43% |
| 8 | SUPN | Supernus | 5.32% |
| 9 | SPTX | Seaport Therapeutics | 5.27% |
| 10 | GHRS | GH Research | 4.98% |
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | DFTXDefinium Therapeutics | Healthcare | 11.88% | $1,187.92 | 153K | $4.5M |
| 2 | CMPSCompass Pathways | Healthcare | 11.25% | $1,125.40 | 494K | $4.3M |
| 3 | HELPHelus Pharma | Healthcare | 7.00% | $699.67 | 392K | $2.7M |
| 4 | LLYELI Lilly | Healthcare | 6.61% | $661.34 | 1,860 | $2.5M |
| 5 | NBIXNeurocrine Biosciences | Healthcare | 6.16% | $616.22 | 15K | $2.3M |
| 6 | ABBVAbbvie | Healthcare | 6.02% | $602.22 | 8,071 | $2.3M |
| 7 | RLMDRelmada Therapeutics | Healthcare | 5.43% | $542.76 | 663K | $2.1M |
| 8 | SUPNSupernus | Healthcare | 5.32% | $532.24 | 71K | $2.0M |
| 9 | SPTXSeaport Therapeutics | Healthcare | 5.27% | $527.10 | 109K | $2.0M |
| 10 | GHRSGH Research | Healthcare | 4.98% | $498.37 | 102K | $1.9M |
| 11 | JNJJohnson & Johnson | Healthcare | 4.81% | $480.99 | 6,842 | $1.8M |
| 12 | ANROAlto Neuroscience | Healthcare | 4.73% | $473.32 | 68K | $1.8M |
| 13 | NRXPNRX Pharmaceuticals | Healthcare | 4.70% | $470.28 | 701K | $1.8M |
| 14 | STIMNeuronetics | Healthcare | 3.58% | $358.50 | 1.1M | $1.4M |
| 15 | DRUGBright Minds Biosciences | Healthcare | 2.63% | $262.65 | 48K | $998K |
PSIL has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| PSIL | −0.06 | −0.09 | 39.8% | −37.8% | 1.20 | $128 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $1.68 |
| Sep 22, 2025 | Sep 29, 2025 | $0.0201 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0119 |
| Mar 21, 2025 | Mar 28, 2025 | $0.16 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0548 |
| Sep 23, 2024 | Sep 30, 2024 | $0.11 |
| Sep 25, 2023 | Sep 29, 2023 | $0.34 |
| Sep 26, 2022 | Sep 30, 2022 | $5.41 |